SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-014814
Filing Date
2023-04-26
Accepted
2023-04-26 16:15:38
Documents
8
Period of Report
2023-06-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A mnov_proxy_2023.htm DEF 14A 1330479
2 GRAPHIC img138344839_0.jpg GRAPHIC 3617
3 GRAPHIC img138344839_1.jpg GRAPHIC 1349
4 GRAPHIC img138344839_2.jpg GRAPHIC 3617
5 GRAPHIC img138344839_3.jpg GRAPHIC 1349
6 GRAPHIC img138344839_4.jpg GRAPHIC 265689
7 GRAPHIC img138344839_5.jpg GRAPHIC 267824
8 GRAPHIC img138344839_6.jpg GRAPHIC 1349
  Complete submission text file 0000950170-23-014814.txt   2081966
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33185 | Film No.: 23849924
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences